The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

EDITORIAL

Sizing for self-expanding transcatheter aortic valve implantation

EuroIntervention 2018;14:e490-e493 published online e-edition August 2018. DOI: 10.4244/EIJV14I5A86

NYU Langone Health, New York, NY, USA


Computed tomography (CT) is the standard of care for device sizing for balloon-expandable (BE) and self-expanding (SE) transcatheter aortic valve implantation (TAVI) and has dramatically impacted outcomes in this field, particularly the frequency of paravalvular aortic regurgitation (PAR)1,2. In this issue of EuroIntervention, Kim et al describe multicentric outcomes of 198 patients treated with a novel SE transcatheter heart valve (THV) device, the Edwards CENTERA (Edwards Lifesciences, Irvine, CA, USA) in the context of CT-based oversizing, as assessed prospectively by a dedicated CT core lab3.

The Edwards CENTERA is a relatively novel THV whose first-in-man (FIM) experience was described ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Urgent balloon aortic valvuloplasty in cardiogenic shock patients: still state of the art in the TAVI era?

Latest news